Diabetes mellitus (diabetes) Nutritional, Metabolic, Endocrine
Conditions
Interventions
Patient HbA1c levels that were collected 3 to 6 months after the start of FreeStyle Libre are compared to HbA1c levels collected prior to starting Libre.
Sponsors
Abbott (United Kingdom) Diabetes Care Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18 years or over 2. Has type 2 diabetes using basal-bolus insulin regimen for at least 1 year 3. Has used FreeStyle Libre/Libre 2 regularly for at least 3 months 4. HbA1c recorded in medical notes between 8.0% and 12.0% (64 to 108 mmol/mol) in the 3 months prior to starting FreeStyle Libre/Libre 2 5. HbA1c recorded in medical notes 3 to 6 months after starting FreeStyle Libre/Libre 2
Exclusion criteria
Exclusion criteria: 1. Female participant who was pregnant during the data collection period 2. Received dialysis treatment during the data collection period 3. Participated in another device or drug study that could have affected glucose measurements or management during the data collection period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin A1c (HbA1c) level measured using the FreeStyle Libre sensor and recorded in medical charts at baseline and 3 to 6 months after initiation | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
England, Northern Ireland, Scotland, United Kingdom, Wales
Contacts
Public ContactPamela Reid
Outcome results
None listed